| 2023-11 |
Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer |
Experimental & Molecular Medicine
|
| 2023-11 |
The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC |
Journal of Molecular Medicine
|
| 2023-10 |
Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea |
Journal of Gastric Cancer
|
| 2023-10 |
CanISO: a database of genomic and transcriptomic variations in domestic dog (Canis lupus familiaris) |
BMC Genomics
|
| 2023-05 |
Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells |
EXPERIMENTAL AND MOLECULAR MEDICINE
|
| 2023-05 |
PHGDH preserves one-carbon cycle to confer metabolic plasticity in chemoresistant gastric cancer during nutrient stress |
Proceedings of the National Academy of Sciences of the United States of America
|
| 2023-03 |
ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer |
Clinical cancer research : an official journal of the American Association for Cancer Research
|
| 2023-02 |
The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus |
Kidney International
|
| 2023-02 |
PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models |
BMC Medicine
|
| 2022-10 |
Single Cell Analysis of Gastric Cancer Reveals Non-Defined Telomere Maintenance Mechanism |
CELLS
|
| 2022-10 |
Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres |
Cancer Cell International
|
| 2022-10 |
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors |
Investigational New Drugs
|
| 2022-09 |
Editorial: Emerging roles and mechanisms of stromal cells in carcinomas at the molecular level |
FRONTIERS IN IMMUNOLOGY
|
| 2022-08 |
Single Cell Analysis Reveals Reciprocal Tumor-Macrophage Intercellular Communications Related with Metabolic Reprogramming in Stem-like Gastric Cancer |
CELLS
|
| 2022-08 |
Cholesterol Synthesis Is Important for Breast Cancer Cell Tumor Sphere Formation and Invasion |
BIOMEDICINES
|
| 2022-07 |
Machine Learning Predictor of Immune Checkpoint Blockade Response in Gastric Cancer |
Cancers
|
| 2022-07 |
Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma |
GASTRIC CANCER
|
| 2022-06 |
Prognosis-related gene signature is enriched in cancer-associated fibroblasts in the stem-like subtype of gastric cancer |
Clinical and Translational Medicine
|
| 2022-06 |
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer |
Cancer Communications
|
| 2022-06 |
Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
|
| 2022-03 |
H-1 NMR based urinary metabolites profiling dataset of canine mammary tumors |
Scientific data
|
| 2022-03 |
New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment |
Cells
|
| 2022-03 |
The Matrisome Is Associated with Metabolic Reprograming in Stem-like Phenotypes of Gastric Cancer |
Cancers
|
| 2022-02 |
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer |
Nature Communications
|
| 2022-01 |
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study |
Gastric Cancer
|
| 2022-01 |
Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials. |
CANCER COMMUNICATIONS
|
| 2021-12 |
Perioperative, short-, and long-term outcomes of gastric cancer surgery: Propensity score-matched analysis of patients with or without prior solid organ transplantation |
EJSO
|
| 2021-11 |
Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers |
SCIENTIFIC REPORTS
|
| 2021-10 |
Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer: Results from two large Korean cohorts |
CHINESE JOURNAL OF CANCER RESEARCH
|
| 2021-10 |
Pan‐Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism |
International Journal of Molecular Sciences
|
| 2021-09 |
Cdx-1/cdx-2 expression is a favorable prognostic factor in epstein-barr virus-negative, mismatch repair-proficient advanced gastric cancers |
GUT AND LIVER
|
| 2021-09 |
Alternative lengthening of telomeres is mechanistically linked to potential therapeutic vulnerability in the stem-like subtype of gastric cancer |
Clinical and translational medicine
|
| 2021-07 |
Long-chain polyphosphates impair SARS-CoV-2 infection and replication |
SCIENCE SIGNALING
|
| 2021-06 |
Sp1-induced FNBP1 drives rigorous 3D cell motility in EMT-type gastric cancer cells |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
|
| 2021-06 |
Long non-coding RNAs are significantly associated with prognosis and response to therapies in gastric cancer |
Clinical and translational medicine
|
| 2021-05 |
SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence |
GASTRIC CANCER
|
| 2021-04 |
Pan?cancer analysis reveals distinct metabolic reprogramming in different epithelial?mesenchymal transition activity states |
Cancers
|
| 2021-03 |
Prognostic Value of Postoperative Neutrophil and Albumin: Reassessment One Month After Gastric Cancer Surgery |
FRONTIERS IN ONCOLOGY
|
| 2021-02 |
Functional inhibition of fatty acid binding protein 4 ameliorates impaired ciliogenesis in GCs |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
|
| 2021-01 |
Matrix stiffness epigenetically regulates the oncogenic activation of the Yes-associated protein in gastric cancer |
Nature biomedical engineering
|
| 2020-10 |
A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer |
CANCER RESEARCH AND TREATMENT
|
| 2020-09 |
FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells |
Redox Biology
|
| 2020-08 |
Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer |
Molecular therapy oncolytics.
|
| 2020-07 |
Cross-species oncogenic signatures of breast cancer in canine mammary tumors |
NATURE COMMUNICATIONS
|
| 2020-07 |
Role of Mitochondria-Cytoskeleton Interactions in the Regulation of Mitochondrial Structure and Function in Cancer Stem Cells |
Cells
|
| 2020-06 |
Contrasting Prognostic Effects of Tumor-Infiltrating Lymphocyte Density in Cardia and Non-cardia Gastric Adenocarcinomas |
Journal of Gastric Cancer
|
| 2020-04 |
Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer |
EJSO
|
| 2019-12 |
Clinical Implications of Microsatellite Instability in Early Gastric Cancer |
Journal of Gastric Cancer
|
| 2019-12 |
The optimal timing of additional surgery after non-curative endoscopic resection to treat early gastric cancer: long-term follow-up study. |
SCIENTIFIC REPORTS
|
| 2019-11 |
Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer |
GASTRIC CANCER
|
| 2019-09 |
Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high-volume Eastern centers and the SEER database. |
JOURNAL OF SURGICAL ONCOLOGY
|
| 2019-09 |
Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response |
ONCOLOGIST
|
| 2019-08 |
Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer Post Hoc Analysis of the CLASSIC Randomized Controlled study |
ANNALS OF SURGERY
|
| 2019-08 |
VEGF-C induced by TGF- beta 1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis |
BMC CANCER
|
| 2019-08 |
Whole-exome and whole-transcriptome sequencing of canine mammary gland tumors |
Scientific Data
|
| 2019-07 |
Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer |
RADIOTHERAPY AND ONCOLOGY
|
| 2019-06 |
Prognostic impact of extended lymph node dissection versus limited lymph node dissection on pn0 proximal advanced gastric cancer: A propensity score matching analysis |
Journal of Gastric Cancer
|
| 2019-06 |
EPB41L5 Mediates TGFβ-Induced Metastasis of Gastric Cancer |
CLINICAL CANCER RESEARCH
|
| 2019-04 |
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial |
CANCER RESEARCH AND TREATMENT
|
| 2019-04 |
A therapeutic strategy for chemotherapy-resistant gastric cancer via destabilization of both β-catenin and ras |
Cancers
|
| 2019-03 |
Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon |
YONSEI MEDICAL JOURNAL
|
| 2019-02 |
Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial |
YONSEI MEDICAL JOURNAL
|
| 2019-01 |
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial |
CANCER RESEARCH AND TREATMENT
|
| 2018-12 |
Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype |
NATURE COMMUNICATIONS
|
| 2018-11 |
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy |
BMC CANCER
|
| 2018-10 |
Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex |
ANNALS OF SURGICAL ONCOLOGY
|
| 2018-10 |
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial. |
ANNALS OF SURGICAL ONCOLOGY
|
| 2018-09 |
Increased extracellular matrix density disrupts E-cadherin/beta-catenin complex in gastric cancer cells |
BIOMATERIALS SCIENCE
|
| 2018-09 |
Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells with Markers of the Epithelial–Mesenchymal Transition, Due to Loss of NAPRT |
GASTROENTEROLOGY
|
| 2018-06 |
Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm |
Journal of Gastric Cancer
|
| 2018-05 |
A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy |
AAPS JOURNAL
|
| 2018-05 |
Inhibition of Wntless/GPR177 suppresses gastric tumorigenesis |
BMB REPORTS
|
| 2018-05 |
Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis |
LANCET ONCOLOGY
|
| 2018-04 |
Long-term outcomes of endoscopic submucosal dissection in comparison to surgery in undifferentiated-type intramucosal gastric cancer using propensity score analysis |
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
|
| 2018-04 |
Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2α-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase Expression. |
CLINICAL CANCER RESEARCH
|
| 2018-01 |
Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer |
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
|
| 2018-01 |
Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin |
EXPERIMENTAL AND MOLECULAR MEDICINE
|
| 2017-10 |
Impact of splenic hilar lymph node metastasis on prognosis in patients with advanced gastric cancer |
ONCOTARGET
|
| 2017-07 |
Distinct expression profile of key molecules in crawling-type early gastric carcinoma |
GASTRIC CANCER
|
| 2017-06 |
Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer |
ONCOTARGET
|
| 2017-05 |
Beyond precision surgery: Molecularly motivated precision care for gastric cancer |
EJSO
|